Please use this identifier to cite or link to this item:
|Title:||Relevance of pharmacogenomics for developing countries in Europe : implementation in the Maltese population|
Fenech, Anthony G.
Borg, Joseph J.
Patrinos, George P.
|Keywords:||Pharmacogenomics -- Developing countries|
Pharmacogenomics -- Malta
Single nucleotide polymorphisms
|Publisher:||Malta Medical Journal|
|Citation:||Malta Medical Journal. 2012, Vol.24(3), p. 8-12|
|Abstract:||Pharmacogenomics is a promising new discipline that can realize personalized treatment for patients suffering from many common diseases, particularly those with multiple treatment modalities. Recent advances in the deciphering of the human genome sequence and high throughput genotyping technology have led to the reduction of the overall genotyping costs and enabled the inclusion of genotype-related dosing recommendations into drug package inserts, hence allowing the integration of pharmacogenomics into clinical practice. Although, pharmacogenomics gradually assumes an integral part in mainstream medical practice in developed countries, many countries, particularly from the developing world, still do not have access either to the knowledge or the resources to individualize drug treatment. The PharmacoGenetics for Every Nation Initiative (PGENI) aims to fill in this gap, by making pharmacogenomics globally applicable, not only by defining population-specific pharmacogenomic marker frequency profiles and formulating country-specific recommendations for drug efficacy and safety but also by increasing general public and healthcare professionals’ awareness over pharmacogenomics and genomic medicine. This article highlights the PGENI activities in Europe and its implementation in the Maltese population, in an effort to make pharmacogenomics readily applicable in European healthcare systems.|
|Appears in Collections:||MMJ, Volume 24, Issue 3|
MMJ, Volume 24, Issue 3
Scholarly Works - FacHScABS
Scholarly Works - FacM&SCPT
Scholarly Works - FacM&SPat
Files in This Item:
|2012.Vol24.Issue3.A2.pdf||Relevance of pharmacogenomics for developing countries in Europe: implementation in the Maltese population||391.53 kB||Adobe PDF||View/Open|
Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.